Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study.


Journal

Haematologica
ISSN: 1592-8721
Titre abrégé: Haematologica
Pays: Italy
ID NLM: 0417435

Informations de publication

Date de publication:
09 2019
Historique:
received: 14 09 2018
accepted: 31 01 2019
pubmed: 2 2 2019
medline: 29 7 2020
entrez: 2 2 2019
Statut: ppublish

Résumé

Asparagine levels in cerebrospinal fluid and serum asparaginase activity were monitored in children with acute lymphoblastic leukemia treated with pegylated-asparaginase. The drug was given intravenously at a dose of 2,500 IU/m

Identifiants

pubmed: 30705097
pii: haematol.2018.206433
doi: 10.3324/haematol.2018.206433
pmc: PMC6717578
doi:

Substances chimiques

Polyethylene Glycols 3WJQ0SDW1A
Asparagine 7006-34-0
pegaspargase 7D96IR0PPM
Asparaginase EC 3.5.1.1

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1812-1821

Informations de copyright

Copyright© 2019 Ferrata Storti Foundation.

Références

J Clin Oncol. 1999 May;17(5):1568-73
pubmed: 10334545
Ann Oncol. 2000 Feb;11(2):189-93
pubmed: 10761754
Blood. 2002 Mar 15;99(6):1986-94
pubmed: 11877270
Anal Biochem. 2002 Oct 1;309(1):117-26
pubmed: 12381370
Leukemia. 2003 Nov;17(11):2254-6
pubmed: 14523472
Br J Haematol. 2004 Apr;125(2):117-27
pubmed: 15059133
Clin Cancer Res. 2004 Aug 15;10(16):5335-41
pubmed: 15328169
Clin Pharmacokinet. 2005;44(4):367-93
pubmed: 15828851
Pediatr Blood Cancer. 2006 Jan;46(1):18-25
pubmed: 15929133
Haematologica. 2006 Jan;91(1):24-31
pubmed: 16434367
Cancer Res. 1991 Dec 15;51(24):6568-73
pubmed: 1742729
Expert Opin Biol Ther. 2009 Jan;9(1):111-9
pubmed: 19063697
N Engl J Med. 2009 Jun 25;360(26):2730-41
pubmed: 19553647
Curr Med Chem. 2010;17(20):2183-95
pubmed: 20423302
Cancer. 2011 Jan 15;117(2):238-49
pubmed: 20824725
Leuk Lymphoma. 2011 Feb;52(2):168-78
pubmed: 21281233
J Control Release. 2012 Jul 20;161(2):461-72
pubmed: 22094104
J Cereb Blood Flow Metab. 2012 Nov;32(11):1959-72
pubmed: 22929442
Br J Haematol. 2014 Jul;166(2):213-20
pubmed: 24702187
Haematologica. 2014 Nov;99(11):1716-21
pubmed: 25150254
Leuk Lymphoma. 2015;56(8):2273-80
pubmed: 25586605
Semin Cell Dev Biol. 2015 Feb;38:2-6
pubmed: 25681530
Blood. 2016 Apr 28;127(17):2101-12
pubmed: 26888258
Clin Chim Acta. 1989 Jul 14;182(3):271-80
pubmed: 2766551
Cancer Chemother Pharmacol. 2017 Jun;79(6):1267-1271
pubmed: 28424964
Ther Drug Monit. 2018 Feb;40(1):93-102
pubmed: 29210976
Pediatr Blood Cancer. 2018 Aug;65(8):e27083
pubmed: 29727043
Cancer. 1970 Feb;25(2):244-52
pubmed: 4905152
Cancer Res. 1981 Nov;41(11 Pt 1):4554-8
pubmed: 6895481
Clin Chem. 1982 Mar;28(3):527-31
pubmed: 7067099
J Clin Oncol. 1995 Feb;13(2):339-44
pubmed: 7844595
Ann Oncol. 1996 Sep;7(7):725-30
pubmed: 8905031
Eur J Cancer. 1996 Aug;32A(9):1544-50
pubmed: 8911116
Br J Haematol. 1997 Mar;96(4):675-81
pubmed: 9074406
Crit Rev Oncol Hematol. 1998 Aug;28(2):97-113
pubmed: 9768345

Auteurs

Carmelo Rizzari (C)

Pediatric Hematology-Oncology Unit, Department of Pediatrics, University of Milano-Bicocca, MBBM Foundation, Monza, Italy c.rizzari@asst-monza.it.

Claudia Lanvers-Kaminsky (C)

Department of Pediatric Hematology and Oncology, University Childrens' Hospital of Münster, Münster, Germany.

Maria Grazia Valsecchi (MG)

Medical Statistics Unit, Department of Clinical Medicine and Prevention, University of Milano-Bicocca, Milan, Italy.

Andrea Ballerini (A)

Department of Oncology, Laboratory of Cancer Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Cristina Matteo (C)

Department of Oncology, Laboratory of Cancer Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Joachim Gerss (J)

Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany.

Gudrun Wuerthwein (G)

Department of Pediatric Hematology and Oncology, University Childrens' Hospital of Münster, Münster, Germany.

Daniela Silvestri (D)

Medical Statistics Unit, Department of Clinical Medicine and Prevention, University of Milano-Bicocca, Milan, Italy.

Antonella Colombini (A)

Pediatric Hematology-Oncology Unit, Department of Pediatrics, University of Milano-Bicocca, MBBM Foundation, Monza, Italy.

Valentino Conter (V)

Pediatric Hematology-Oncology Unit, Department of Pediatrics, University of Milano-Bicocca, MBBM Foundation, Monza, Italy.

Andrea Biondi (A)

Pediatric Hematology-Oncology Unit, Department of Pediatrics, University of Milano-Bicocca, MBBM Foundation, Monza, Italy.

Martin Schrappe (M)

Department of Pediatrics, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany.

Anja Moericke (A)

Department of Pediatrics, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany.

Martin Zimmermann (M)

Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.

Arend von Stackelberg (A)

Pediatric Hematology and Oncology, Charité, Berlin, Germany.

Christin Linderkamp (C)

Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.

Michael C Frühwald (MC)

Children's Hospital, Augsburg, Germany.

Sabine Legien (S)

Pediatrics 5 (Oncology, Hematology, Immunology); Stuttgart Cancer Center; Klinikum Stuttgart - Olgahospital, Stuttgart, Germany.

Andishe Attarbaschi (A)

Department of Pediatric Hematology and Oncology, St. Anna Children's Hospital, Vienna, Austria.

Bettina Reismüller (B)

Department of Pediatric Hematology and Oncology, St. Anna Children's Hospital, Vienna, Austria.

David Kasper (D)

Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.

Petr Smisek (P)

Czech Paediatric Haematology/Oncology, Charles University and University Hospital Motol, Prague, Czech Republic.

Jan Stary (J)

Czech Paediatric Haematology/Oncology, Charles University and University Hospital Motol, Prague, Czech Republic.

Luciana Vinti (L)

Department of Pediatric Hemato-Oncology, Ospedale Bambino Gesù, Rome, Italy.

Elena Barisone (E)

Department of Pediatric Hemato-Oncology, Regina Margherita Children's Hospital, Turin, Italy.

Rosanna Parasole (R)

Department of Pediatric Hematology-Oncology, Ospedale Pausillipon, Naples, Italy.

Concetta Micalizzi (C)

Department of Pediatric Hematology-Oncology, IRCCS I.G. Gaslini, Genova, Italy.

Massimo Zucchetti (M)

Department of Oncology, Laboratory of Cancer Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.

Joachim Boos (J)

Department of Pediatric Hematology and Oncology, University Childrens' Hospital of Münster, Münster, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH